Notice2024-18175
Foreign-Trade Zone (FTZ) 61, Notification of Proposed Production Activity; Boehringer Ingelheim Animal Health Puerto Rico LLC; (Animal Health Products); Barceloneta, Puerto Rico
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 14, 2024
Issuing agencies
Commerce DepartmentForeign-Trade Zones Board
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 157 (Wednesday, August 14, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 157 (Wednesday, August 14, 2024)]
[Notices]
[Pages 66032-66033]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-18175]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-44-2024]
Foreign-Trade Zone (FTZ) 61, Notification of Proposed Production
Activity; Boehringer Ingelheim Animal Health Puerto Rico LLC; (Animal
Health Products); Barceloneta, Puerto Rico
Boehringer Ingelheim Animal Health Puerto Rico LLC, submitted a
notification of proposed production activity to the FTZ Board (the
Board) for its facility in Barceloneta, Puerto Rico within Subzone
61AC. The notification conforming to the requirements of the Board's
regulations (15 CFR 400.22) was received on August 8, 2024.
Pursuant to 15 CFR 400.14(b), FTZ production activity would be
limited to the specific foreign-status material/component and specific
finished product described in the submitted notification (summarized
below) and subsequently authorized by the Board. The benefits that may
stem from conducting production activity under FTZ procedures are
explained in the background section of the Board's website--accessible
via <a href="http://www.trade.gov/ftz">www.trade.gov/ftz</a>. The proposed finished product and material/
component would be added to the production authority that the Board
previously approved for the operation, as reflected on the Board's
website.
The proposed finished product is finished/packaged heartworm
treatment chewable tablets for canines (duty-free).
The proposed foreign-status material/component is moxidectin (duty
rate of 3.7%). The request indicates that the material/component is
subject to duties under section 301 of the Trade Act of 1974 (section
301), depending on the country of origin. The applicable section 301
decisions require subject merchandise to be admitted to FTZs in
privileged foreign status (19 CFR 146.41).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
<a href="/cdn-cgi/l/email-protection#7711030d37030516131259101801"><span class="__cf_email__" data-cfemail="3056444a7044425154551e575f46">[email protected]</span></a>. The closing period for their receipt is September 23,
2024.
A copy of the notification will be available for public inspection
in the ``Online FTZ Information System'' section of the Board's
website.
For further information, contact Kolade Osho at
<a href="/cdn-cgi/l/email-protection#bcf7d3d0ddd8d992f3cfd4d3fcc8ceddd8d992dbd3ca"><span class="__cf_email__" data-cfemail="fab195969b9e9fd4b5899295ba8e889b9e9fd49d958c">[email protected]</span></a>.
[[Page 66033]]
Dated: August 8, 2024.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2024-18175 Filed 8-13-24; 8:45 am]
BILLING CODE 3510-DS-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 14, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.